Category Archives: Antibody-drug Conjugates Manufacturing

24Jan/25

The Future of Cancer Care: What Antibody-Drug Conjugates Will Bring and What We Have Already Done

January 24, 2025Antibody-drug Conjugates Manufacturing, Antibody-drug Conjugates Research, Newsadc research, ADC Therapy, antibody drug conjugatesbioadc

Among all emerging technologies for cancer therapy, one is both highly accurate and efficient: Antibody-Drug Conjugates (ADCs). These missiles are the first such missiles that allow us to kill cancer cells while doingRead More…

28Dec/21

New structures to resolve the instability of Maleimide joint

December 28, 2021Antibody-drug Conjugates ManufacturingADC, ADC linker, Hydrolyzed Maleimide linkerbioadc

An ADC consists of an antibody and toxin bridged by a linker that affects the coupling stability to some extent and has an important influence on ADC efficacy. The premature release ofRead More…

01Mar/18

The Expanding Field of Antibody-Drug Conjugates (ADCs)

March 1, 2018Antibody-drug Conjugates Manufacturing, Antibody-drug Conjugates Research, Newsadc clinical trials, adc research, antibody drug conjugate pepline, antibody drug conjugatesbioadc

Antibody-drug conjugates or ADCs have emerged as a powerful and strategic tool in the targeted treatment of cancer. These relatively novel agents combine the ability of monoclonal antibodies to specifically target tumor cells,Read More…